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Abstract
Background: Research involving gene expression profiling and clinical applications, such as diagnostics and
prognostics, often require a DNA array platform that is flexibly customisable and cost-effective, but at the same
time is highly sensitive and capable of accurately and reproducibly quantifying the transcriptional expression of a
vast number of genes over the whole transcriptome dynamic range using low amounts of RNA sample. Hereto, a
set of easy-to-implement practical optimisations to the design of cDNA-based nylon macroarrays as well as sample
33P-labeling, hybridisation protocols and phosphor screen image processing were analysed for macroarray
performance.
Results: The here proposed custom macroarray platform had an absolute sensitivity as low as 50,000 transcripts
and a linear range of over 5 log-orders. Its quality of identifying differentially expressed genes was at least
comparable to commercially available microchips. Interestingly, the quantitative accuracy was found to correlate
significantly with corresponding reversed transcriptase - quantitative PCR values, the gold standard gene expression
measure (Pearson’s correlation test p < 0.0001). Furthermore, the assay has low cost and input RNA requirements
(0.5 μg and less) and has a sound reproducibility.
Conclusions: Results presented here, demonstrate for the first time that self-made cDNA-based nylon macroarrays
can produce highly reliable gene expression data with high sensitivity and covering the entire mammalian
dynamic range of mRNA abundances. Starting off from minimal amounts of unamplified total RNA per sample, a
reasonable amount of samples can be assayed simultaneously for the quantitative expression of hundreds of genes
in an easily customisable and cost-effective manner.
Background
DNA arrays are widely used for the comprehensive gene
expression analysis of an organism or sample. Arrays are
available as high-density microarrays capable of covering
the whole genome of an organism, and as low-density cus-
tom arrays containing a specific set of genes. High-density
microarrays are mainly used during the stages of experi-
mental discovery and hypothesis generation, custom arrays
are suitable for hypothesis-driven research. Custom arrays
allow researchers to focus on broad sets of genes or gene
polymorphisms specific to particular cell populations, sig-
nalling pathways or disease conditions, while providing
ultimate control over the experimental design. In general,
specifically tailored macroarrays are more suitable than
microarrays for diagnosis, drug discovery and validation,
and for prognostic assessment of clinical treatments due
to their low levels of background noise, flexibility, and
lower price [1]. In contrast to gene expression analysis by
reverse-transcriptase quantitative PCR (RT-qPCR), which
is well-suited for sensitive analysis of a limited number of
target genes, focused arrays allow cost-effective assessment
of hundreds of targets in a large number of patients [2].
Various versions of DNA array methods exist with
respect to probe substrate and detection method [3]. At
present, commercially available custom DNA arrays are
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almost always printed on glass slides, and detection and
quantification rely on measurement of fluorescence
intensity of hybridised fluorochrome-labelled samples,
with good to excellent sensitivity and reproducibility
[4-6]. However, commercially available glass arrays are
still not commonly used within the wider research com-
munity, as the need for highly specialised equipment
restricts the application of this technology to a small
number of dedicated laboratories. Additionally, the costs
are still very high for large-scale studies. Moreover, most
commercially available arrays still require amplification
of the mRNA mixture before labelling and hybridisation
[7]. Although linear amplification protocols appear to
work reasonably well [8], the risk of skewing relative
abundances when amplifying such a complex mixture
remains a concern [9-11].
Nylon arrays are appreciated as a relatively economical
and user-friendly alternative to other high-throughput
gene expression technologies and have a high do-it-your-
self potential [9]. To date, however, the features of com-
mercial arrays have not been rivalled by in-house nylon
arrays and little to no information is provided in the litera-
ture on custom assay parameters, such as detection limit,
linear range, accuracy and reproducibility, or on practical
issues concerning sample amount, hybridisation protocol
and array construction [12,13]. The last detailed paper on
this subject dates back to 1999 [3].
Here, we describe the construction of a customisable
cDNA-based macroarray platform capable of expression
profiling of sub-microgram amounts of unamplified total
RNA. Included are a set of easy-to-implement optimisa-
tions leading to a substantial increase in sensitivity and
linear range. Our custom system is quick, flexible and
cost-effective. It is based on commercially available equip-
ment and can be easily implemented in any conventional
research laboratory.
Results
Limitations imposed by intrinsic material properties
Out of the macroarray systems, the least demanding
setup in terms of laboratory infrastructure is the cDNA-
based nylon membrane using 33P radioactivity for detec-
tion. cDNA probes are easy to generate by PCR, while
printing on nylon membranes is more straightforward
and requires less specific equipment than, for example,
on glass chips. At the same time, use of 33P for labelling
(33P-dCTP incorporated during reverse transcription) and
a phosphor screen for detection should ensure high sensi-
tivity and a wide dynamic range. To assess the limitations
imposed by this setup on sensitivity, different amounts of
33P-dCTP were manually spotted on a nylon membrane,
which was then exposed to a Bio-Rad phosphor screen
and scanned in a conventional phosphor-imager at
50-μm resolution. Scans revealed that quantities down to
~1 cpm could be detected (Figure 1A). This corresponds
to roughly 125,000 33P-dCTP molecules or half a million
total nucleotides, which indicates that as few as 1,000
hybridised copies of a 500-nt sequence can be detected.
Additionally, when exposure time was varied, the inten-
sity of the detected signal was found to be linear over
time at a rate of 0.45 per hour per deposited cpm (Figure
1B). Therefore, the measured signal per hour of exposure
corresponds directly to the amount of nucleotides on the
membrane. As an implication hereby, Figure 1 illustrates
that the linear range of detection will expand from about
three to five log-values when all individual spots could be
Figure 1 Signal quantification of manually spotted volumes of 33P-dCTP. A) Signal intensity of scanned spots after exposure for 30 min (full
circles), 3 h 30 min (open squares) and 48 h (open triangles), as quantified by our analysis software. B) Signal intensity of the same scans
expressed per hour of exposure.
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exposed for an optimal timeframe. A way to practically
engage this option is to print cDNA-probes that generally
generate high intensity spots on a separate membrane
from the low intensity spots. This and other considera-
tions for getting the most out of our custom cDNA-
based nylon macroarray platform with 33P radioactivity
are given below.
Optimising the array design for image quantification and
normalisation
After selection of the macroarray setup, we determined
the optimal printing parameters and layout for our plat-
form with regard to output data quality. Printing was
performed using a Flexsys robotic workstation equipped
with a 384-pin head. For six arbitrarily chosen genes,
saturation of the radioactive signal of a single hybridisa-
tion reaction was reached for 10 ng of printed probe
cDNA (not shown). To ensure maximal signals for each
array, even in the case of small variations in the printing
efficiency, we therefore chose to print 20 ng cDNA per
spot, which corresponds to five transfers of the pin
head.
The output of the phosphor-imager is a 16-bit image,
which implies a range of 65,536 greyscales. Considering a
background value of six for an unexposed screen, the
resulting dynamic range of a single scan is four log-
orders. To optimally exploit this dynamic range, a sensi-
tive background correction is essential. In typical micro-
array experiments, quantified spot intensities are
corrected with a local background value based on the
intensities of pixels just outside the spot area. However,
an intrinsic characteristic of radioactive signals is that
spots are not well delineated. Consequently, local back-
ground values determined in the spot vicinity would be
proportional to the actual spot intensity, which would
lead to disproportionate overcorrection. We therefore
constructed a background image by extrapolating the
local minima across the entire array. This background
image was then subtracted from the original image,
which enabled us to visualise and reliably quantify spots
that were marginally above the background value and in
that way fully utilise the dynamic range (Figure 2A).
Following background correction, the spots are automati-
cally localised and quantified, and the data are exported
Figure 2 Procedure flowchart for software image analysis. A) Background correction, B) spot detection, quantification and data storage, and
C) batch macroarray normalisation, including a composite picture of the normalised spots over all arrays in the batch. In each distribution
histogram of spot intensity ratios between two arrays, the 30% genes with maximal area under the curve that thus represent the bulk gene-
population with the lowest differential expression, were selected and the median thereof calculated. The normalisation factor for a given array
pair was then defined by the difference of this median to 1, and the geometrical mean of all the pair-wise normalisation factors as the global
normalisation factor for a given array. M = median, fi(A) = normalisation factor for A to correct against a given other macroarray, fN(A) = global
batch normalisation factor for macroarray A.
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to a text file by custom-made ImageJ add-on scripts
(available upon request with the corresponding author)
(Figure 2B). Also a scatter plot of the duplicate spots is
generated for every analysed macroarray scan as an
immediate indication of the overall quality (Figure 2B).
In addition, a batch script features macroarray normalisa-
tion and generation of a series of log-transformed and
normalised images of each spot over all the arrays ana-
lysed automatically (Figure 2C). Hereto, a custom nor-
malisation approach was developed.
In commercial array platforms, normalisation is typi-
cally based on the assumption that the average expres-
sion ratio of either a subset or of all genes on the array
should be equal to one. For whole-genome platforms this
is a fair assumption, as the large background of non-
differential genes compensates for the limited number of
highly differential genes which may be present. However,
highly differential genes might bias such normalisation
when using focused arrays that are strongly enriched in
genes that might be differentially expressed. Normalisa-
tion of our custom arrays was therefore performed by
calculating an individual normalisation factor for each
pair-wise combination of arrays, using the 30% least dif-
ferentially expressed genes in order to minimise the like-
lihood of a normalisation bias (Figure 2C). The global
normalisation factor for a given array in the batch was
then calculated as the geometrical mean of all its indivi-
dual pair-wise normalisation factors with the other arrays
in the batch (Figure 2C). This approach is thus robust as
long as not more than 70% of all genes on the array are
differentially expressed between all samples in the batch,
which is rarely the case. It is ideally suited for low density
arrays as it does not require a set of housekeeping genes,
the expression of which is assumed to stay stable within
the experiment.
As mentioned above, poor delineation of the spots is an
intrinsic property of radioactive signals. This means that
despite solid background correction during image analy-
sis, spots should readily be printed at sufficient distances
to ensure minimal overspill of signal between neighbour-
ing spots, but close enough to maximise utilisation of the
membrane area. To this end, spots with varying intensi-
ties were quantified (Figure 3A). Despite differences in
spot intensity, the shape of the curve of pixel intensities
throughout the spot diameter was invariant (Figure 3B).
Modelling of this shape revealed that logarithmic decay
of the signal started at 600 μm (12 pixels) from the spot
centre, and that quantification of the spot area within a
circle with 600 μm (12 pixel) radius yielded 85% of the
total signal (Figure 3C). The minimal distance between
two individual spots should therefore be at least 1.2 mm
(2 × 600 μm). However, to limit signal overspill between
neighbouring spots, we designed a medium-density lay-
out with a minimal spot distance of 2 mm.
Subsequently, the potential overspill between spots at
2 mm distance was modelled (Figure 3D), based on the
per pixel signal range between about 20 (background)
and 65,000 (saturation) on a 16-bit tiff image and on the
above modelled paraboloid spot shape (see also Figure
3C). With a tenfold difference in signal, i.e. with one
spot reaching intensity saturation in its centre peak
pixel and the second spot with a maximal intensity
value of 6,500, 0.16% of the lower signal was caused by
overspill from the adjacent spot with the higher signal
(Figure 3E). This overspill value increased to 1.55% for a
hundredfold difference between the maximal intensities
of the adjacent spots and to 13.61% for a thousand fold
difference (Figure 3E). To avoid a problematical 33.3%
signal overspill, maximum intensities of neighbouring
spots should not differ by more than about 3,000-fold
(Figure 3E).
This restriction imposed by the current array design
constrains the upper detection limit and therefore also
imposes a limitation on the linear range of detection:
highly abundant genes can lead to rapid saturation of the
signal and to significant signal overspill when differing by
over 3,000-fold in intensity from the neighbouring spot.
To increase the linear range of detection, we separated
typically high from typically low intensity probes over
two membranes. These two sets were identified by hybri-
disations of pooled samples derived from a broad spec-
trum of macrophage activation models. In this way, high
and low intensity membranes could be exposed for opti-
mal durations without over-exposing the high intensity
or under-exposing the low intensity spots. Additionally,
large differences in signal intensity between neighbouring
spots were precluded.
Optimising the hybridisation conditions and use of
sample RNA
Macroarray sensitivity depends significantly on both the
quality and quantity of input 33P-dCTP labelled cDNA.
From a research point of view, working with unamplified
sub-microgram total RNA samples would be optimal. To
evaluate this possibility, variations in the hybridisation
and cDNA-synthesis protocols were evaluated.
We found that hybridisation concentrations could
be scaled up from the traditionally used 106 cpm/ml to
107 cpm/ml without significant increase in background
noise. This increase thus improved the detection sensi-
tivity for transcripts of low abundance while maintaining
absolute sensitivity. In a first optimisation assay, this
tenfold increase in hybridisation concentration resulted
in a tenfold increase of the specific signal (from 433 to
4,324) and a twofold increase (from 12 to 21) of the
background noise intensity, thus implying a fivefold
increase of the signal-to-noise ratio. In routine practice,
this higher hybridisation concentration of 107 cpm/ml
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reproducibly generated average background intensity
values of approximately 20. In practice, the high hybridi-
sation concentration of up to 107 cpm/ml was reached
with sub-microgram amounts (0.5 μg) of unamplified
total RNA by hybridising the blots in standard conical
50-ml tubes with buffer volumes down to 2 ml.
At the level of cDNA synthesis, label incorporation
and suitability for array hybridisation was analysed for
different amounts of input RNA. Interestingly, analysis
by alkaline gel electrophoresis (Figure 4A) revealed that
cDNA generated from small amounts of total RNA,
which contains less 33P-dCTP than higher amounts of
total RNA (as was measured by liquid scintillation
counting), contained more fragments of longer length
(Figure 4B). Figure 4B shows that when 10 μg of total
RNA were used, which is common for most macroarray
platforms, only 21% of the fragments were copied to
cDNA to an average 21% of fragment length (4% of
mRNA copied), but when 0.5 μg of RNA was used, 53%
of the fragments were copied to an average 40% of frag-
ment length (21% of mRNA copied). Quite likely, small
input amounts do not exhaust the reverse transcription
reaction quickly, and so more and longer cDNA frag-
ments are synthesised. It also implies that such cDNA
should perform better in array hybridisations. To verify
this, samples with different amounts of input RNA were
Figure 3 Modelling of spot shape and intensity. A) Log-transformed pictures of a selection of six macroarray spots of different intensities. B)
Determination of the spot intensity profile from spots depicted in A by measurement of the pixel intensity as a function of the pixel distance
from the spot centre. C) Determination of the general spot shape (black curve) by expressing the intensity at each distance for every spot as a
fraction of the maximum intensity (grey lines). Full vertical lines represent 85% of the area under the curve at a diameter of 24 pixels (1.2 mm);
dashed vertical lines represent the spot distance on the macroarray membrane (at 40 pixels = 2 mm). D) Mathematical modelling of the
potential signal overspill between two adjacent spots 2 mm apart. Maximal intensity of neighbouring spot and measured spot are indicated,
with the ratio between brackets. E) Signal measured within the 1.2-mm diameter around the lower intensity spot centre for the respective
situations illustrated in panel D. Percentages denote which fraction of the integrated signal intensity is caused by overspill from the
neighbouring maximal intensity spot.
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spiked with equal amounts of control luciferase mRNA
and subsequently labelled and hybridised at equal cpm
amounts to membranes containing oligo-probes at the
3’-end and 5’-end of the luciferase transcript. Indeed,
larger amounts of input RNA resulted in decreased sig-
nal intensity of the probe positioned more towards 5’-
end, while the probe spots designed to recognise
sequences located more towards the 3’-end showed
more stable intensity (Figure 4C). This ‘less-is-more’
effect reached its optimum with 0.5 μg input RNA.
When < 0.5 μg was used, spot intensities decreased
equally for oligo-probes for 3’-end and 5’-end regions,
probably because of simple dosage effects. The observa-
tion that less input RNA yields longer and better quality
cDNA for array hybridisation is further supported by
the performance of certain gene-probes on the macroar-
ray (additional file 1: S1.TIF). Although the correlation
was not absolute and most likely depended on each spe-
cific mRNA sequence (e.g. internal polyA-stretches),
there was a clear correlation between the upstream posi-
tion of the probe and the length-distribution of the
cDNA. This also underscores that the observed effect is
not specific to the luciferase control mRNA. In conclu-
sion, increased assay sensitivity was achieved by (i) using
Figure 4 Optimising reverse transcription for minimal sample input and maximal cDNA quality. A) 105 cpm of cDNA samples from
reverse transcriptase reactions with the indicated amounts of input total RNA were analyzed for length distribution by electrophoresis in 1%
alkaline agarose. Full length synthesis was obtained by adding cold dCTP. B) Summary of the efficiency of cDNA synthesis and 33P-dCTP
incorporation based on both liquid scintillation counting measured before and after the reverse transcriptase reaction and the cDNA length
distribution, calculated from the alkaline gel picture in panel A as the weighted signal intensity per fragment length. The average fragment
length, the 33P-dCTP incorporation values, as well as the number of fragments generated from different amounts of input total RNA were
calculated and compared to the full-length synthesised sample. As a deduction thereof, also the mass proportion of mRNA in the sample that
was transcribed was calculated, taking into account the assumptions made in the methods section ‘Calculations, estimates and constants’. The
black vertical line indicates the amount used in all other macroarray assays. Results shown in A-B are representative for two independent
experiments. C) Membrane spot intensities (± variation on duplicate spots) generated by a given amount of luciferase control transcript spiked
into different amounts of mouse peritoneal macrophage total RNA when hybridised at equal cpm with two different oligo-cDNA probes on the
nylon membrane. Probes were designed to bind 3’-end or 5’-end sequences. The results confirm the quality of cDNA made from 0.5 μg total
RNA (black vertical line) is suitable for array hybridisation.
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0.5 μg of total RNA to ensure effective label incorpora-
tion while yielding high quality cDNA with respect to
length and composition, and (ii) using small hybridisa-
tion volumes (2 ml) in order to have high hybridisation
concentrations.
Assessment of efficiency and array sensitivity
The sensitivity of the macroarray platform was assessed
on the basis of relative and absolute sensitivity. Relative
sensitivity is the detection threshold for a specific
mRNA within the total RNA pool whereas absolute sen-
sitivity is the minimum number of molecules of a given
mRNA that must be present in a sample of total RNA
in order to produce a signal. Both relative and absolute
sensitivity are a direct consequence of the labelling and
hybridisation efficiencies. To measure relative and abso-
lute sensitivity, samples were spiked with a serial dilu-
tion of control transcripts encoding either kanamycin or
luciferase. As a measure of absolute sensitivity, spikes of
luciferase mRNA between 54,700 and 170,000 tran-
scripts (55 fg and 170 fg, respectively) could be reliably
detected (Additional file 2: S2.PDF). Calculating from
this absolute value the relative sensitivity requires an
assumption of the amount of mRNA present within the
total RNA sample and the number of mRNA transcripts
contained herein. These values were calculated from the
assay efficiency values, which yielded an approximate
relative sensitivity in the range of 1/300,000 to 1/
1,200,000 transcripts or - in most cases - the equiva-
lence of one transcript per cell (Additional file 2: S2.
PDF).
Assessment of array reproducibility
All cDNA probes on the macroarray were spotted in
duplicate, which made it possible to assess internal
reproducibility. Plotting the duplicate spot intensities in
a randomly selected hybridisation against each other
showed that less than 3% of them deviated more than
twofold from each other (Figure 5A). To assess the
reproducibility between different arrays, technical
repeats were performed by independently labelling a
sample twice, followed by hybridisation to two separate
arrays within the same batch of hybridisations (i.e. label-
ling reaction with the same batch of 33P-dCTP, identical
exposure conditions). No genes showed more than a
twofold deviation between the two arrays (Figure 5B).
Validation of qualitative and quantitative array accuracy
To evaluate how the fully optimised custom array setup
compares with other technologies, several analyses were
performed in parallel on our mouse and human MAS
macroarrays and on other well established gene expres-
sion platforms. Qualitative performance was assessed by
comparing the ability of the human MAS focus array to
pick up differentially expressed genes that were identified
by the commercial CodeLink HWG platform. To this
end, samples from monocytes of individual HIV-patients
and healthy controls were hybridised in parallel to the
MAS macroarray and to commercial CodeLink HWG
microarrays, as described for a study published elsewhere
[14]. Datasets composed of only genes represented on
both arrays were filtered according to three criteria: (i) p-
value as determined by Student’s t test <0.05; (ii) a spot
Figure 5 Reproducibility of the macroarray platform. Arrays were generated as described and hybridisations were performed with 33P-
labelled samples derived from thioglycolate-elicited peritoneal excudate cells. Signal intensities of individual spots of duplicates on the same
array (A), and average signal intensities of duplicate spots of two different arrays (B) were plotted against each other. Spots with an intensity
deviating more than twofold in either direction are displayed in red.
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quality flag G (’good’, a quality flag assigned by the Code-
Link software package) in all CodeLink HWG arrays or
variation between spot replicates ≤20% in all MAS arrays;
(iii) a fold change between the means of the two groups
≥1.5. With this approach, both the CodeLink and MAS
array platforms identified four genes as differentially
expressed in the patient and control groups. The MAS
array identified five other genes that were not significant
according to the CodeLink analysis, whereas CodeLink
microarrays did not identify any additional genes within
the defined set of common genes (Table 1). All differen-
tially expressed genes identified by both platforms as well
as the additional genes picked up by our MAS array were
confirmed to be true positives by an independent RT-
qPCR analysis of the same samples. The qualitative iden-
tification of differentially expressed genes by our custom
array platform is therefore at least comparable to com-
mercially available setups.
Finally, the quantitative performance of our platform
was assessed by comparing MAS array and RT-qPCR
expression data. Differential gene expression was ana-
lysed in a study of splenic macrophages from tumour-
bearing versus control mice, as documented elsewhere
[15]. Genes showing more than a twofold difference in
expression in MAS macroarray profiling were analysed
using RT-qPCR: fold changes were very similar between
the two setups (p < 0.0001 according to a Pearson’s cor-
relation test), which shows the usefulness of the macro-
array platform as a semi-quantitative gene expression
analysis tool (Figure 6).
Discussion
We developed a focused gene expression profiling plat-
form capable of simultaneously assaying the qualitative
and quantitative expression of hundreds of genes in a
reasonably large amount of biological samples. Our sys-
tem requires only basic laboratory equipment and can
be used in common clinical and/or laboratory settings.
All results discussed here are based on our Macrophage
Activation State array (human and mouse) focusing on
genes involved in the immunobiology of cells of macro-
phage lineage. However, the same setup can be readily
applied to other species and/or other cell types or
tissues.
In the scope of this paper, the macroarray setup and
assay were optimised for the following crucial parameters:
Linear range
A system designed for the simultaneous analysis of several
hundreds of genes must be linear over an expression
range that ideally covers the ~ 4.5 orders of magnitude of
the mammalian transcriptome. Use of 33P-based labelling
is the first factor in extending linear range; we show that
the 33P signal is linear over the required range and that it
remains linear over time. While radioactive labels ensure
high sensitivity and a linear range, they suffer from the
problem of overspill, which is not experienced with con-
ventional fluorescent dyes: spots with high intensity can
outshine and erroneously contribute to the intensity of
neighbouring spots. To fully utilise the linear range inher-
ent to the use of 33P, overspill must be minimised. To this
end, spot quantification range and minimal spot distance
were calculated and implemented. Using our setup, an
erroneous 1.5-fold increase in signal intensity is theoreti-
cally possible only when the highest and lowest expressed
genes are spotted adjacently.
A second challenge to our setup is that the inherent
linear range of 33P is compromised by limits of the
detection system. The phosphor-imager renders the
exposed phosphor screens to a 16-bit tiff image, and
saturation is therefore reached at an intensity of ~
65,000. As background intensities are ~ 20 in this 16-bit
image, the range is effectively reduced to ~ 3.5 orders of
magnitude. This problem was solved by spotting genes
of high and low abundance on different membranes,
which are hybridised together but exposed separately for
the optimal times. In this way, the phosphor-imager lin-
ear range of 3.5 orders of magnitude is required to
Table 1 Differential gene-expression between monocytes from HIV-patients and healthy controls, compared to
microarray and RT-qPCR results
Gene OGS Gene Entrez ID MAS-macroarray CL-HWG RT-qPCR
p-value* fold change p-value* fold change fold change
CAPG 822 0.0375 -1.76 n.s. 1.09 -2.02
CCR1 1230 0.0240 2.16 n.s. 1.32 2.21
CDKN1A 1026 0.0012 1.91 0.0066 1.59 1.76
IL1F7 27178 0.0480 -1.58 n.s. 1.05 -2.12
NAMPT 10135 0.0381 2.34 0.0010 1.56 2.56
PDCD1LG2 80380 0.0087 -3.19 0.0065 1.68 -3.15
PTGER2 5732 0.0477 1.57 n.s. 1.22 1.85
STAT1 6772 0.0164 2.40 0.0004 1.52 2.25
YWHAZ 7534 0.0429 1.75 n.s. 1.06 1.51
OGS: Official Gene Symbol, MAS: Macrophage Activation State, CL-HWG: CodeLink Human Whole Genome microarray. * Student’s t-test.
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cover only part of the transcriptome, and the signal per
hour values of both membranes combined easily cover
the 4.5 log-orders needed. Additionally, the problem of
signal overspill is further reduced, because genes of high
and low abundance are kept separate and will therefore
not be printed adjacently.
Sensitivity
Use of 33P-based labelling also allowed us to obtain high
sensitivity. Furthermore, detection of low-abundant tran-
scripts was enhanced, probably down to one out of a mil-
lion, by increasing the hybridisation concentration to 107
cpm/ml, decreasing signal overspill, and generating more
and longer cDNA from sub-microgram amounts of input
RNA. Sensitivity was further enhanced by our image ana-
lysis approach to background correction, which is well-
adapted for detection and quantification of radioactive sig-
nals marginally above background levels. Taken together,
our setup can detect down to 50,000 fragments of a spiked
mRNA species.
Reproducibility
To avoid high signal variability due to differences in the
quantity of printed probes, cDNA was spotted on the
membranes at concentrations well above saturation
levels. Additionally, we applied a ‘less-is-more’ approach
to mRNA reverse transcription. Use of large amounts of
input RNA in the reverse transcription/labelling reaction
can quickly exhaust the reverse transcriptase reaction
and result in very short cDNA fragments. This might
render the sample prone to greater variability as a result
of minute differences in reverse transcription efficiency,
especially for genes for which the corresponding probe
printed on the array is more distal from the 3’-end of
the mRNA fragment. Use of smaller amounts of input
RNA (0.5 μg) resulted in cDNA of higher quality in
terms of fragment number and length.
Cost-effectiveness
Using the proposed minimal spot distance of 2 mm, a
10 cm × 7 cm nylon membrane can accommodate 384
genes printed in duplicate, and multiple membranes can
be used in the same hybridisation reaction. Expression
of several hundred genes can therefore be analysed
quantitatively in a sample of < 1 μg. Furthermore, the
array platform described here can be constructed and
used in most laboratories with standard equipment,
which avoids the need to outsource valuable samples for
transcriptome analysis and keeps costs low. Array print-
ing could be the main bottleneck, as we have used a
Figure 6 Quantitative validation of the MAS array platform. Fold changes as assessed by RT-qPCR and the MAS-macroarray platform for 17
individual genes differing at least twofold on the macroarray in a study of splenic macrophages from progressive tumour-bearing versus control
mice. p-value of a Pearson correlation test is shown. MAS: Macrophage Activation State.
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robotic work station to accurately spot each cDNA
probe. However, the possibility of printing cDNA for
microarray construction using conventional inkjet print-
ing technology was first mentioned almost ten years ago
[16]. The costs of the system presented here can be
further reduced by stripping off the hybridised material
and re-using the nylon membranes. We have deter-
mined empirically that stripping and reusing the mem-
branes twice does not significantly affect their accuracy
and reproducibility.
The array platform described here has many possible
applications. First, it can be used downstream of gen-
ome-wide microarray analyses. The genes identified in a
genome-wide gene expression analysis can be incorpo-
rated in a focused array, which can then be used for fol-
low-up experiments or confirmation of gene expression
results in a wider range of samples. Second, it can also
serve as a rapid screening tool for complex phenotypes
that cannot be characterised by using only one or even
several parameters. Third, it can be used in clinical stu-
dies, which typically require many samples to achieve suf-
ficient statistical power, as a substitute for costly
microarray systems. In particular, our focused system
could be a suitable alternative to many commercially
available options when there is some knowledge of a col-
lection of genes of interest or of a particular cell type
under study.
Conclusions
In conclusion, we have constructed a custom macroarray
platform ideally suited for the investigation of an inter-
mediate number of genes, in particular when sample
material is scarce or when the study population is large.
Our custom approach is robust and flexible. It has several
advantages and fits well into present research laboratory
practices.
Methods
All technological optimisations were performed in an
array setup focused on myeloid cell populations -the so-
called Macrophage Activation State (MAS) macroarray -
which was used in all optimisation experiments and
quality assessment procedures described here.
Array construction
For macroarray construction, a cDNA pool was gener-
ated by oligo-dT mediated reverse transcription of total
RNA of monocytes/macrophages under various in vitro
and ex vivo conditions. cDNA probes were generated by
PCR amplification of the cDNA pool using gene-specific
primers (Table 2). The PCR products were purified by
filtration over Multiscreen PCR96 filter plates (Millipore,
Billerica, MA, USA), resuspended in nuclease-free water,
and separated by agarose gel electrophoresis to evaluate
the size of the PCR products and efficiency of the PCR
reaction. Products from failed PCR reactions (no PCR
product or PCR product with more than one band or of
an unexpected size) were excluded, and the remaining
PCR products were air-dried overnight at 52°C and
resuspended in 2× saline-sodium citrate (SSC) buffer
with 0.4 M NaOH by five cycles of 30 s at 85°C and
30 s at 20°C. Macroarrays were prepared by spotting the
PCR products in duplicate on 7 × 10 cm Hybond-XL
membranes (Amersham GE Healthcare, Buckingham-
shire, UK) using a Flexsys robotic workstation (Genomic
Solutions, Ann Arbor, MI, USA) equipped with a 384-
pin head, followed by cross-linking using UV light.
33P-dCTP labelling
For the sample labelling reaction, 0.125 μg oligo-dT T8
primer (Invitrogen, Carlsbad, CA, USA) was added to the
total RNA sample, and the mixture was denatured for
10 min at 70°C. cDNA probes were then generated by
reverse transcription with Superscript II reverse transcrip-
tase (Invitrogen) in the presence of 33P-dCTP (0.05 mCi/
sample; PerkinElmer, Waltham, MA, USA), dATP, dTTP
and dGTP (each 100 μM; Invitrogen), and RNase inhibitor
(Promega, MA, USA). After cDNA synthesis, 60 mM
EDTA and 150 mM NaOH were added, the sample was
incubated for 10 min at 42°C, after which 250 mM Tris-
HCl (pH 6.8) was added. Subsequently, probes were puri-
fied using ProbeQuant G-50 Micro Columns (Amersham
GE Healthcare) according to the manufacturer’s instruc-
tions, and radioactivity incorporation was determined by
liquid scintillation counting.
Array hybridisation and data acquisition
Before hybridisation, macroarray membranes were
washed in 2 × SSC and pre-incubated for 1 h at 42°C in 2
ml NorthernMax hybridisation buffer (Ambion, Austin,
TX, USA) containing 40 μg/ml heat-denatured salmon
testes DNA (Sigma-Aldrich, Saint-Louis, MO, USA).
Probes were denatured for 5 min at 95°C. Hybridisation
was performed at high probe concentration (107 cpm/ml)
in 2 ml NorthernMax hybridisation buffer in 50 ml coni-
cal tubes for 20 h at 42°C with continuous rotation.
Table 2 Characteristics of gene-specific primers for probe
cDNA generation
Parameter Limits
Primer length 16-25 nt
Primer Tm 52-60°C
Primer dTm ≤ 2°C
3’ pentamer stability 8.5 -kc/M
Product size 250-550 bp (tolerated 250-750 bp)
Product location 3’ proximal 1000 nt (tolerated 1500 nt)
Product Tm 70-90°C
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Membranes were then washed three times in 2 × SSC
buffer with 1% SDS, and twice in 0.6 × SSC with 1% SDS
for 30 min at 68°C. Moistened filters were wrapped in
plastic and exposed to a phosphor screen to reveal bound
radioactivity. Phosphor screens were scanned with a
phosphor-imager (BioRad Personal Molecular Imager
FX, Hercules, CA, USA) at 50 μm resolution. Phosphor-
imager output files were converted to 16-bit tiff images
using the software application Quantity One (BioRad).
The files were then for signal quantification using Java-
based custom designed software on the freely available
ImageJ platform (http://rsbweb.nih.gov/ij/).
Samples
For optimisation and sensitivity testing of the custom
array, total RNA was isolated from ex vivo LPS-stimu-
lated mouse peritoneal macrophages with the Aurum
total RNA mini kit (BioRad), according to manufac-
turer’s instructions, and RNA yield was measured using
a NanoDrop spectrophotometer (Thermo Scientific,
Waltham, MA, USA). Where mentioned in the results
section, samples were spiked with firefly luciferase or
kanamycin control mRNA (Promega). Samples for the
quality assessment of our array setup were collected and
processed in the context of a study on monocyte-HIV
interactions, as documented elsewhere [14], and in a
study of splenic macrophages from BW-Sp3 tumour-
bearing versus control AKR mice [15].
cDNA alkaline gel electrophoresis
Samples of 105 cpm of the 33P-dCTP labelled cDNA
were loaded in the slots of a 1% agarose gel made with
running buffer (5 M NaOH/0.5 M EDTA) and run at 40
V for 3 h. The marker was generated by labelling of the
phage l HindIII marker with 33P-dCTP in a Klenow
reaction, and the full length cDNA was generated by
also adding 100 μM cold dCTP to the reverse transcrip-
tase reaction. After neutralisation in 7% TCA, the gel
was dried under vacuum, wrapped in foil, and exposed
overnight to a phosphor screen. The resulting back-
ground-subtracted image was normalised for a constant
total signal per lane for further analysis of fragment
length distribution.
Microarrays
Gene expression analysis of human samples was com-
pared with datasets collected using CodeLink HWG
bioarrays (Amersham Biosciences, Freiberg, Germany),
which were used according to the manufacturer’s
instructions and were analysed as described elsewhere
[14]. Datasets are available at the EMBL-EBI repository
(accession number E-MEXP-2255).
Quantitative RT-PCR
mRNA expression of genes of interest was examined
using RT-qPCR. cDNA was prepared from 1 μg total
RNA using oligo-dT and Superscript II reverse tran-
scriptase (Invitrogen). Gene-specific primers different
from the primers used for microarray probe generation
were used in duplicate PCR reactions (Bio-Rad iQ SYBR
Green Supermix) on a Bio-Rad MyCycler. Mouse gene
expression was normalised against the housekeeping
gene, ribosomal protein S12 (Rps12, Gene Entrez ID
20042).
Calculations, estimates and constants
• The lower prosphorscreen detection limit of the radio-
active signal on a nylon Hybond-XL membrane, was
empirically found to be 1 cpm or 6.23 × 10-8 μl of a 10-
μCi/μl batch of 33P-dCTP at 3 μCi/pmol, which there-
fore corresponds to 2.1 10-19 moles, or about 125,000
molecules (when multiplied by Avogadro’s constant).
• Starting from 0.5 μg total RNA, reverse transcription
for radioactive labelling generated cDNA fragments with
an average length of about 500 nucleotides as deduced
from alkaline gel electrophoresis. This fragment length
was used for further calculations.
• A 25% dCTP proportion in cDNA fragments is
assumed.
• Where relevant, the proportion of mRNA in a sam-
ple of total RNA from mouse macrophages was esti-
mated to be 5%.
Additional material
Additional file 1: Figure S1 - cDNA quality depends on input RNA
amount. The left panel represents a scheme of the upstream distance
on the mRNA transcript recognised by the gene-specific macroarray
oligo-cDNA probe for a set of 23 genes. The right panel shows the log-
transformed, normalised spots of this panel after hybridisation with the
cDNA of different length distributions, generated from the indicated
amounts of RNA input of a single sample. Although lower input RNA,
resulting in longer cDNA, gives a good spot signal for all genes listed,
this signal faints with higher input RNA, especially for spots with probes
recognising more upstream transcript sequences. Some oligo-probes (e.g.
for Hnrpa2b1, Cd164, Vegfa and Cdkn1a) seem to be more resistant to
the effect of input RNA amount on the cDNA length distribution, which
might be explained by the existence of internal polyA stretches or
differences in secondary and tertiary mRNA folding.
Additional file 2: Macroarray efficiency and sensitivity calculations.
The pdf-file contains a figure (Figure S2) and a detailed description of
the methodology as well as the used calculations to derive the
macroarray efficiency parameters and both absolute and relative
sensitivity parameters as they are summarized in the results section
‘Assessment of efficiency and array sensitivity’.
List of abbreviations used
MAS: Macrophage Activation State; RT-qPCR: Reverse Transcriptase -
quantitative PCR
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